Sharma Nishant, Sachedina Ayaaz K, Kumar Sachin
Libin Cardiovascular Institute, Foothills Medical Centre, University of Calgary, Calgary, Canada.
Memorial Hermann-Texas Medical Center, University of Texas Health Science Center, Houston, TX, USA.
Heart Int. 2023 Jan 17;17(1):8-12. doi: 10.17925/HI.2023.17.1.8. eCollection 2023.
Aortic stenosis (AS) is a common valve pathology experienced by patients worldwide. There are limited population-based studies assessing its prevalence; however, epidemiological studies emphasize that the burden of disease is growing. Recognizing AS relies on accurate clinical assessment and diagnostic investigations. Patients who develop severe AS are often referred to the heart team for assessment of aortic valve intervention. Although echocardiography has traditionally been used to screen and monitor the progression of AS, there can be discordance between measurements in a low-flow state. Such patients may have truly severe AS and potentially derive long-term benefit from aortic valve intervention. Accurately identifying these patients with the use of ancillary testing has been the focus of research for several years. In this article, we discuss the contemporary approaches and challenges in identifying and managing patients with low-flow, low-gradient severe AS.
主动脉瓣狭窄(AS)是全球患者中常见的瓣膜病变。基于人群评估其患病率的研究有限;然而,流行病学研究强调疾病负担正在增加。认识AS依赖于准确的临床评估和诊断检查。出现严重AS的患者通常会被转诊至心脏团队进行主动脉瓣干预评估。尽管传统上超声心动图用于筛查和监测AS的进展,但在低流量状态下测量结果可能存在不一致。这类患者可能确实患有严重AS,并且可能从主动脉瓣干预中获得长期益处。使用辅助检查准确识别这些患者多年来一直是研究重点。在本文中,我们讨论识别和管理低流量、低梯度严重AS患者的当代方法及挑战。